foxo4-dri peptide senolytic 2023 inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis The disordered p53 transactivation domain
Description
246 In recent years, increasing evidence has shown that the PI3K/AKT signaling pathway is closely associated with the occurrence and development of UC and is also an important signaling pathway for targeted UC therapy
Independent laboratory testing is performed to confirm compound identity, purity levels, and batch consistency
Evidence Limitations No human RCTs
In sports, BPC-157 is banned
